Marijuana Enforcement Division 2027 Regulatory Agenda

CDOR Marijuana Enforcement Division Regulatory Agenda Report

The Colorado Department of Revenue (CDOR) submits the following 2027 Regulatory Agenda (Agenda) in fulfillment of the statutory requirements set forth in §2-7-202(6), 2-7-203, and 24-4-103.3(4), C.R.S. Pursuant to state law, annually on November 1 executive-branch agencies must file their Agenda. 
Per §2-7- 202(6), C.R.S., the Agenda must contain: 

  • (a) A list of new rules or revisions to existing rules that the department expects to propose in the next calendar year;
  • (b) The statutory or other basis for adoption of the proposed rules;
  • (c) The purpose of the proposed rules;
  • (d) The contemplated schedule for adoption of the rules;
  • (e) An identification and listing of persons or parties that may be affected positively or negatively by the rules.

The Agenda is to be filed with Legislative Council Staff for distribution to committee(s) of reference, posted on CDOR’s website, and submitted to the State Library, the Colorado Department of Regulatory Agencies, and the Secretary of State for publication in the Colorado Register. CDOR must also present its Agenda as part of its “SMART Act” presentation pursuant to §2-7-203(2)(a), C.R.S. CDOR works with several boards and commissions that promulgate rules; for ease of use for the consumer, those rules are included in CDOR's Agenda. The Agenda covers Calendar Year 2027(CY27).

Marijuana Enforcement Division 2027 Regulatory Agenda
Schedule (month)Rule Number and Title (or Description) (ex: 1 CCR 201-1, Rule #101)New rule, revision, or repeal?Statutory or other basis for adoption of rule (ex: 2-3-401, C.R.S.)Part of Mandatory Rule Review? X if yesPurpose (Purpose for the change, ex: legislation)StakeholdersAnticipated Hearing Date
Jul.1 CCR 212-3, Parts 1 through 8Revision[PLACEHOLDER] Since August 2025, MED has been subject to a performance audit requested by Sens. B. & R. Pelton during the 2025 legislative session. The MED anticipates revisions to the Marijuana Rules will be needed as a result of the audit recommendations, particularly to product- and consumer safety-related rules. The audit hearing will be held on Monday, October 19 before the Legislative Audit Committee.MED Stakeholder ListFall 2027
Aug.1 CCR 212-3 Rule 1-115Revision44-10- 202(1)(c), 44-10-202(1)(j), and 44-10-103, C.R.S.XPursuant to section 24-4-103.3, C.R.S. and based on stakeholder feedback regarding vaporizer delivery devices and multi-batch products.MED Stakeholder ListFall 2027
Jul.1 CCR 212-3 Rule 2-100 through 2-140 FeesRevision44-10-103, 44-10-202(1)(b), 44-10-202(1)(c), 44-10-202(1)(e), 44-10-203(1)(k), 44-10-203(1)(i), 44-10-203(2)(b), 44-10-203(2)(h), 44-10-203(2)(q), 44-10-203(2)(w), 44-10-203(2)(dd)(XII), 44-10-303(2)(b), 44-10-310(7), 44-10-313, 44-10-401, 44-10-801, 44-10-802, 44-10-803, 44-10-1201, 44-10-1202, C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(II). Statutory mandate to evaluate fees annually to reflect direct and indirect costs of administering the program.MED Stakeholder ListFall 2027
Jul.1 CCR 212-3 Rule 2-145 Social Equity FeesRevision44-10-103, 44-10-202(1)(b), 44-10-202(1)(c), 44-10-202(1)(e), 44-10-203(1)(k), 44-10-203(1)(i), 44-10-203(2)(b), 44-10-203(2)(h), 44-10-203(2)(q), 44-10-203(2)(w), 44-10-203(2)(dd)(XII), 44-10-303(2)(b), 44-10-308(5); 44-10-310(7), 44-10-313, 44-10-401, 44-10-801, 44-10-802, 44-10-803, 44-10-1201, 44-10-1202, C.R.S Statutory mandate to evaluate fees annually to reflect direct and indirect costs of administering the program. Additionally, the State Licensing Authority is expressly permitted by statute to adopt reduced fees for Social Equity Licensees.MED Stakeholder ListFall 2027
Aug.1 CCR 212-3 Rule 3-905 Business Records RequiredRevision44-10- 202(1)(c), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-301, and 44-10-1001(1), (3), and (4), C.R.S. Based on stakeholder feedback concerning vaporizer delivery devices.MED Stakeholder ListFall 2027
Aug.1 CCR 212-3 Rule 3-335 Production of Regulated Marijuana Concentrate and Regulated Marijuana Products: Specific Health and Safety RequirementsRevision44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(2)(g), 44-10-203(2)(h), 44-10-203(2)(i), 44-10-202(2)(y), 44-10-203(3)(b), 44-10-203(3)(c), 44-10-203(3)(d), 44-10-203(3)(e), 44-10-203(3)(g), and 44-10-1001, C.R.S.XPursuant to section 24-4-103.3, C.R.S. and based on stakeholder feedback regarding multi-batch products.MED Stakeholder ListFall 2027
Aug.1 CCR 212-3 Rule 3-805 Regulated Marijuana Businesses: Inventory Tracking SystemRevision44-10-201(1), 44-10-202(1)(a), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(h), 44-10-501(1)(b), 44-10-502(2), 44-10-503(1)(b), 44-10-505(3), 44-10-601(1)(d), 44-10-602(3), 44-10-603(1)(b), 44-10-605(3), and 44-10-610(3)(a), C.R.S.XPursuant to section 24-4-103.3, C.R.S. and based on stakeholder feedback regarding multi-batch products.MED Stakeholder ListFall 2027
Aug.1 CCR 212-3 Rule 3-1005 Packaging and Labeling: Minimum Requirements Prior to Transfer to a Regulated Marijuana Business, except to a Regulated Marijuana Testing FacilityRevision44-10-202(1)(a), 44-10-202(1)(c), 44-10-202(6), 44-10-203(2)(f), 44-10-203(1)(k), 44-10-203(3)(a)-(b), 44-10-601(2)(a), 44-10-601(5), 44-10-603(1)(d), 44-10-603(4)(a), and 44-10-603(8), C.R.S.XPursuant to section 24-4-103.3, C.R.S. and based on stakeholder feedback regarding multi-batch products.MED Stakeholder ListFall 2027
Aug.1 CCR 212-3 Rule 3-1010 – Packaging and Labeling: General Requirements Prior to Transfer to a Patient or ConsumerRevision44-10-202(1)(a), 44-10-202(1)(c), 44-10-202(6), 44-10-203(2)(f), 44-10-203(1)(k), 44-10-203(3)(a)-(b), 44-10-601(2)(a), 44-10-601(5), 44-10-603(1)(d), 44-10-603(4)(a), and 44-10-603(8), C.R.S.XPursuant to section 24-4-103.3, C.R.S. and based on stakeholder feedback regarding multi-batch products.MED Stakeholder ListFall 2027
Aug.1 CCR 212-3 Rule 4-225 – Regulated Marijuana Testing Program: Sampling ProceduresRevision44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44-10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44-10-504(1)(b), 44-10-504(2), 44-10-601(4), 44-10-602(4), 44-10-603(6), 44-10-604(1)(b), and 44-10-604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII).XPursuant to section 24-4-103.3, C.R.S. and based on stakeholder feedback regarding multi-batch products.MED Stakeholder ListFall 2027
Aug.1 CCR 212-3 Rule 4-250 – Regulated Marijuana Testing Program: Vaporizer Delivery Device Required TestingNew44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(g), 44-10-203(1)(k), 44-10-203(2)(d), 44-10-203(2)(f), 44-10-203(3)(d), 44-10-203(3)(e), 44-10-501(6), 44-10-502(3), 44-10-503(8), 44-10-504(1)(b), 44-10-504(2), 44-10-601(4), 44-10-602(4), 44-10-603(6), 44-10-604(1)(b), and 44-10-604(2), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(VII). Based on stakeholder feedback concerning vaporizer delivery devices.MED Stakeholder ListFall 2027
Aug.1 CCR 212-3 Rule 5-310 – Medical Marijuana Products Manufacturer: General Limitations or Prohibited ActsRevision44-10-202(1)(c), 44-10-203(1)(k), 44-10-401(2)(a)(III), and 44-10-503, C.R.S. Based on stakeholder feedback concerning vaporizer delivery devices.MED Stakeholder ListFall 2027
Aug.1 CCR 212-3 Rule 6-310 – Retail Marijuana Products Manufacturer: General Limitations or Prohibited ActsRevision44-10-202(1)(c), 44-10-203(1)(a), 44-10-203(1)(c), 44-10-203(1)(k), 44-10-203(2)(f), 44-10-203(2)(g), 44-10-203(2)(h), 44-10-203(2)(i), 44-10-203(2)(y), 44-10-203(2)(aa), 44-10-203(3)(d), 44-10-401(2)(b)(III), 44-10-401(2)(b)(VIII), 44-10-603, 44-10-608, and 44-10-701(2)(a), C.R.S. Authority also exists in the Colorado Constitution at Article XVIII, Subsection 16(5)(a)(V). Based on stakeholder feedback concerning vaporizer delivery devices.MED Stakeholder ListFall 2027